Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)
Sponsored by Leap Therapeutics, Inc.
Active
$568.2K Funding
7 People
External
Related Topics
colorectal cancer,
treatment,
clinical trial,
dkn-01,
chemotherapy
People
Rachna Shroff
Co-Investigator (COI)
Medicine
﹒Professor
Junaid Arshad
Co-Investigator (COI)
Medicine
﹒Assistant Professor, Medicine - (Clinical Scholar Track)
Hina Arif Tiwari
Co-Investigator (COI)
Pathology and Lab Medicine
﹒Professor
Umbreen Rozell
Co-Investigator (COI)
Medicine
﹒Assistant Clinical Professor, Medicine - (Clinical Series Track)
Gustavo Cornejo
(CD)
Senior VP Health Sciences
﹒Research Compliance Administrator III
Diana Dawson
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I